Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bone Neoplasms | 8 | 2020 | 2532 | 1.770 |
Why?
|
Osteosarcoma | 4 | 2020 | 897 | 1.500 |
Why?
|
Choristoma | 4 | 2021 | 207 | 1.440 |
Why?
|
Lung Diseases | 14 | 2024 | 1915 | 1.190 |
Why?
|
Testicular Neoplasms | 5 | 2024 | 801 | 1.040 |
Why?
|
Prostate | 4 | 2022 | 1793 | 1.000 |
Why?
|
Death, Sudden | 2 | 2024 | 302 | 0.970 |
Why?
|
Fractures, Spontaneous | 2 | 2016 | 231 | 0.920 |
Why?
|
Ribonuclease III | 3 | 2020 | 279 | 0.920 |
Why?
|
Genital Neoplasms, Male | 1 | 2024 | 68 | 0.900 |
Why?
|
DEAD-box RNA Helicases | 3 | 2020 | 383 | 0.860 |
Why?
|
Sarcoma | 7 | 2020 | 1786 | 0.860 |
Why?
|
Liver Diseases | 2 | 2021 | 1302 | 0.780 |
Why?
|
Pulmonary Blastoma | 4 | 2023 | 41 | 0.760 |
Why?
|
Diarrhea, Infantile | 1 | 2021 | 101 | 0.750 |
Why?
|
Transducin | 1 | 2020 | 42 | 0.740 |
Why?
|
Hypertension, Pulmonary | 11 | 2024 | 1570 | 0.730 |
Why?
|
Malabsorption Syndromes | 1 | 2021 | 135 | 0.730 |
Why?
|
Infant | 61 | 2024 | 36060 | 0.720 |
Why?
|
Tibia | 2 | 2017 | 1065 | 0.720 |
Why?
|
Uterine Cervical Diseases | 1 | 2020 | 74 | 0.700 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 2 | 2024 | 494 | 0.690 |
Why?
|
Adenoma, Pleomorphic | 3 | 2018 | 75 | 0.690 |
Why?
|
Eye | 1 | 2024 | 710 | 0.690 |
Why?
|
Wilms Tumor | 4 | 2017 | 375 | 0.670 |
Why?
|
Umbilical Cord | 1 | 2021 | 181 | 0.670 |
Why?
|
Vaginal Diseases | 1 | 2020 | 103 | 0.670 |
Why?
|
Soft Tissue Neoplasms | 6 | 2020 | 1152 | 0.660 |
Why?
|
Fetal Death | 1 | 2021 | 434 | 0.650 |
Why?
|
Epidermal Cyst | 1 | 2019 | 64 | 0.650 |
Why?
|
Child | 80 | 2024 | 79806 | 0.640 |
Why?
|
Metaplasia | 5 | 2022 | 320 | 0.640 |
Why?
|
Polyps | 5 | 2013 | 197 | 0.630 |
Why?
|
Fasciitis | 3 | 2014 | 67 | 0.620 |
Why?
|
Salivary Gland Neoplasms | 3 | 2019 | 304 | 0.620 |
Why?
|
Child, Preschool | 57 | 2024 | 42063 | 0.620 |
Why?
|
Adaptor Proteins, Signal Transducing | 8 | 2022 | 2895 | 0.610 |
Why?
|
Sacrum | 2 | 2019 | 277 | 0.590 |
Why?
|
Immunohistochemistry | 21 | 2022 | 11071 | 0.580 |
Why?
|
Hamartoma | 1 | 2019 | 235 | 0.570 |
Why?
|
Chondrosarcoma | 1 | 2019 | 296 | 0.570 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2019 | 243 | 0.560 |
Why?
|
Rhabdomyosarcoma | 3 | 2020 | 359 | 0.550 |
Why?
|
Respiratory System Abnormalities | 2 | 2021 | 67 | 0.540 |
Why?
|
Cystic Adenomatoid Malformation of Lung, Congenital | 3 | 2021 | 41 | 0.530 |
Why?
|
Oncogene Proteins, Fusion | 8 | 2020 | 1596 | 0.520 |
Why?
|
Hirschsprung Disease | 1 | 2017 | 163 | 0.510 |
Why?
|
Ascitic Fluid | 1 | 2015 | 189 | 0.500 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2015 | 64 | 0.500 |
Why?
|
Fallopian Tube Neoplasms | 2 | 2015 | 328 | 0.500 |
Why?
|
Tunica Intima | 1 | 2017 | 459 | 0.500 |
Why?
|
Wrist | 1 | 2016 | 219 | 0.490 |
Why?
|
Humans | 186 | 2024 | 760621 | 0.480 |
Why?
|
Palate, Soft | 1 | 2015 | 100 | 0.480 |
Why?
|
Radius | 2 | 2016 | 440 | 0.480 |
Why?
|
Translocation, Genetic | 8 | 2009 | 1388 | 0.480 |
Why?
|
Adolescent | 59 | 2024 | 87810 | 0.470 |
Why?
|
Lung | 23 | 2024 | 9994 | 0.460 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2008 | 452 | 0.440 |
Why?
|
Ciliary Motility Disorders | 1 | 2013 | 51 | 0.430 |
Why?
|
Ablation Techniques | 1 | 2015 | 248 | 0.420 |
Why?
|
Infant, Newborn | 29 | 2024 | 26181 | 0.420 |
Why?
|
Chordoma | 1 | 2015 | 346 | 0.410 |
Why?
|
Frozen Sections | 1 | 2013 | 153 | 0.410 |
Why?
|
Rectum | 1 | 2017 | 895 | 0.410 |
Why?
|
Sertoli Cell Tumor | 2 | 2023 | 36 | 0.410 |
Why?
|
Female | 114 | 2024 | 391270 | 0.410 |
Why?
|
Biopsy | 9 | 2024 | 6771 | 0.400 |
Why?
|
Lung Diseases, Interstitial | 4 | 2022 | 911 | 0.400 |
Why?
|
Tumor Suppressor Proteins | 5 | 2021 | 2802 | 0.390 |
Why?
|
Male | 110 | 2024 | 359744 | 0.390 |
Why?
|
Cytodiagnosis | 1 | 2015 | 442 | 0.390 |
Why?
|
Histones | 3 | 2024 | 2583 | 0.390 |
Why?
|
Epithelial Cells | 2 | 2021 | 3663 | 0.390 |
Why?
|
Lung Transplantation | 5 | 2024 | 1305 | 0.380 |
Why?
|
Liver | 4 | 2021 | 7509 | 0.380 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 2 | 2023 | 113 | 0.380 |
Why?
|
Mediastinal Neoplasms | 2 | 2011 | 402 | 0.360 |
Why?
|
Postoperative Care | 1 | 2017 | 1479 | 0.360 |
Why?
|
Ovarian Neoplasms | 6 | 2023 | 4878 | 0.360 |
Why?
|
Pilomatrixoma | 1 | 2010 | 24 | 0.360 |
Why?
|
Pathology | 2 | 2016 | 270 | 0.350 |
Why?
|
Genital Neoplasms, Female | 2 | 2005 | 533 | 0.350 |
Why?
|
Laryngeal Neoplasms | 5 | 2009 | 514 | 0.350 |
Why?
|
Cilia | 2 | 2013 | 493 | 0.340 |
Why?
|
Hair Diseases | 1 | 2010 | 72 | 0.340 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2010 | 246 | 0.340 |
Why?
|
Cholecystitis | 1 | 2010 | 181 | 0.330 |
Why?
|
Spinal Neoplasms | 1 | 2015 | 716 | 0.320 |
Why?
|
Spinal Fractures | 1 | 2015 | 702 | 0.320 |
Why?
|
Immunocompromised Host | 4 | 2017 | 857 | 0.320 |
Why?
|
Paramyxoviridae Infections | 2 | 2010 | 57 | 0.320 |
Why?
|
Trisomy | 1 | 2010 | 260 | 0.320 |
Why?
|
Gallbladder | 1 | 2010 | 305 | 0.310 |
Why?
|
Cholelithiasis | 1 | 2010 | 408 | 0.310 |
Why?
|
Pilonidal Sinus | 1 | 2008 | 16 | 0.310 |
Why?
|
Lung Neoplasms | 11 | 2023 | 13262 | 0.310 |
Why?
|
Neoplasms, Fibroepithelial | 1 | 2008 | 8 | 0.310 |
Why?
|
Orthopedics | 1 | 2017 | 892 | 0.310 |
Why?
|
Buttocks | 1 | 2008 | 111 | 0.300 |
Why?
|
Osteotomy | 1 | 2013 | 836 | 0.290 |
Why?
|
Tomography, X-Ray Computed | 18 | 2023 | 20509 | 0.290 |
Why?
|
Ossification, Heterotopic | 1 | 2010 | 235 | 0.290 |
Why?
|
Carcinoma, Mucoepidermoid | 3 | 2019 | 89 | 0.290 |
Why?
|
Dermoid Cyst | 1 | 2008 | 92 | 0.290 |
Why?
|
Fibrosarcoma | 2 | 2020 | 308 | 0.290 |
Why?
|
Granulosa Cell Tumor | 2 | 2023 | 72 | 0.280 |
Why?
|
Nasopharyngeal Neoplasms | 3 | 2011 | 286 | 0.280 |
Why?
|
Cystadenocarcinoma, Serous | 3 | 2020 | 479 | 0.270 |
Why?
|
Lipoma | 1 | 2008 | 292 | 0.270 |
Why?
|
Neoplasm, Residual | 4 | 2024 | 1007 | 0.270 |
Why?
|
Cell Differentiation | 5 | 2021 | 11481 | 0.270 |
Why?
|
Spinal Dysraphism | 1 | 2008 | 174 | 0.270 |
Why?
|
Professional Practice | 1 | 2008 | 313 | 0.270 |
Why?
|
Vascular Malformations | 1 | 2011 | 464 | 0.260 |
Why?
|
Chromosome Aberrations | 4 | 2008 | 1764 | 0.260 |
Why?
|
Orthopedic Procedures | 1 | 2015 | 1263 | 0.260 |
Why?
|
Chromosomes, Human, Pair 19 | 4 | 2009 | 347 | 0.260 |
Why?
|
Tongue Neoplasms | 1 | 2007 | 183 | 0.250 |
Why?
|
Chromosomes, Human, Pair 15 | 4 | 2009 | 362 | 0.250 |
Why?
|
Vulva | 1 | 2005 | 82 | 0.250 |
Why?
|
Laryngostenosis | 1 | 2007 | 167 | 0.250 |
Why?
|
Skin Neoplasms | 3 | 2010 | 5799 | 0.240 |
Why?
|
Carcinoma | 2 | 2010 | 2331 | 0.240 |
Why?
|
Pelvis | 2 | 2019 | 743 | 0.240 |
Why?
|
Scrotum | 1 | 2005 | 116 | 0.240 |
Why?
|
Sarcoma, Synovial | 2 | 2003 | 151 | 0.240 |
Why?
|
Rhodotorula | 1 | 2024 | 3 | 0.240 |
Why?
|
Polyporales | 1 | 2024 | 6 | 0.240 |
Why?
|
Immunoenzyme Techniques | 5 | 2002 | 1705 | 0.230 |
Why?
|
Specimen Handling | 3 | 2020 | 707 | 0.230 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2005 | 167 | 0.230 |
Why?
|
Sudden Infant Death | 2 | 2024 | 291 | 0.230 |
Why?
|
Autopsy | 5 | 2017 | 1007 | 0.230 |
Why?
|
Pediatrics | 3 | 2022 | 3586 | 0.220 |
Why?
|
Calcinosis | 2 | 2022 | 1476 | 0.220 |
Why?
|
Androgens | 2 | 2022 | 1291 | 0.220 |
Why?
|
Budd-Chiari Syndrome | 1 | 2023 | 24 | 0.220 |
Why?
|
Troponin I | 1 | 2007 | 638 | 0.220 |
Why?
|
Carney Complex | 1 | 2023 | 15 | 0.220 |
Why?
|
Thyroglossal Cyst | 1 | 2003 | 31 | 0.210 |
Why?
|
Head and Neck Neoplasms | 4 | 2020 | 2882 | 0.210 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 4 | 2024 | 1139 | 0.210 |
Why?
|
Bone Marrow | 1 | 2013 | 2912 | 0.210 |
Why?
|
Vulvar Neoplasms | 1 | 2005 | 263 | 0.210 |
Why?
|
In Situ Hybridization, Fluorescence | 9 | 2009 | 2506 | 0.210 |
Why?
|
Mouth Neoplasms | 1 | 2008 | 593 | 0.210 |
Why?
|
Retrospective Studies | 31 | 2024 | 80372 | 0.210 |
Why?
|
Microscopy, Electron, Transmission | 3 | 2013 | 697 | 0.200 |
Why?
|
Brain Neoplasms | 3 | 2020 | 8986 | 0.200 |
Why?
|
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2022 | 24 | 0.200 |
Why?
|
Nuclear Proteins | 5 | 2011 | 5791 | 0.200 |
Why?
|
Radiography, Thoracic | 3 | 2024 | 1296 | 0.200 |
Why?
|
Macrophages, Alveolar | 3 | 2018 | 409 | 0.200 |
Why?
|
Bone Transplantation | 2 | 2017 | 922 | 0.190 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2022 | 1547 | 0.190 |
Why?
|
Umbilicus | 1 | 2001 | 39 | 0.190 |
Why?
|
Single Umbilical Artery | 1 | 2021 | 3 | 0.190 |
Why?
|
Young Adult | 16 | 2024 | 58741 | 0.190 |
Why?
|
STAT5 Transcription Factor | 1 | 2022 | 264 | 0.190 |
Why?
|
Hepatoblastoma | 2 | 2013 | 88 | 0.190 |
Why?
|
Muscle, Skeletal | 3 | 2017 | 4925 | 0.190 |
Why?
|
Receptor, trkA | 2 | 2019 | 159 | 0.190 |
Why?
|
Myocardium | 2 | 2007 | 4700 | 0.190 |
Why?
|
Indenes | 1 | 2021 | 58 | 0.190 |
Why?
|
Kidney Neoplasms | 7 | 2018 | 4312 | 0.180 |
Why?
|
Polycythemia | 1 | 2021 | 125 | 0.180 |
Why?
|
Leukemia, Myelomonocytic, Acute | 1 | 2020 | 38 | 0.180 |
Why?
|
Diagnosis, Differential | 13 | 2023 | 12965 | 0.180 |
Why?
|
Leukemic Infiltration | 1 | 2020 | 47 | 0.180 |
Why?
|
Neuroendocrine Cells | 1 | 2021 | 62 | 0.180 |
Why?
|
Giant Cells | 1 | 2001 | 185 | 0.180 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 381 | 0.180 |
Why?
|
Bronchial Diseases | 1 | 2021 | 151 | 0.180 |
Why?
|
Fingers | 1 | 2003 | 506 | 0.180 |
Why?
|
Arm | 1 | 2003 | 583 | 0.170 |
Why?
|
Encephalitis | 1 | 2024 | 437 | 0.170 |
Why?
|
Paraganglioma | 1 | 2021 | 142 | 0.170 |
Why?
|
Granular Cell Tumor | 1 | 2000 | 48 | 0.170 |
Why?
|
Fibroma | 1 | 2001 | 190 | 0.170 |
Why?
|
Parotid Neoplasms | 3 | 2007 | 157 | 0.170 |
Why?
|
Optic Disk | 1 | 2024 | 421 | 0.170 |
Why?
|
Abdominal Neoplasms | 1 | 2001 | 286 | 0.170 |
Why?
|
Lysine | 2 | 2024 | 1001 | 0.170 |
Why?
|
Extracellular Matrix | 3 | 2016 | 1726 | 0.170 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2020 | 102 | 0.170 |
Why?
|
Liver Transplantation | 2 | 2023 | 2325 | 0.160 |
Why?
|
Fallopian Tubes | 2 | 2011 | 178 | 0.160 |
Why?
|
Genes, abl | 1 | 1999 | 69 | 0.160 |
Why?
|
Iron-Sulfur Proteins | 2 | 2019 | 83 | 0.160 |
Why?
|
Haploinsufficiency | 1 | 2021 | 329 | 0.160 |
Why?
|
Endothelial Cells | 9 | 2024 | 3539 | 0.160 |
Why?
|
Phosphoproteins | 3 | 2018 | 2440 | 0.160 |
Why?
|
Tomography, X-Ray | 1 | 2018 | 60 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2007 | 3484 | 0.160 |
Why?
|
Neoplasms, Connective and Soft Tissue | 1 | 2019 | 34 | 0.160 |
Why?
|
Cannabidiol | 1 | 2020 | 117 | 0.160 |
Why?
|
Penile Neoplasms | 1 | 2000 | 162 | 0.160 |
Why?
|
Nephroma, Mesoblastic | 1 | 2018 | 24 | 0.160 |
Why?
|
Biliary Atresia | 1 | 2019 | 88 | 0.160 |
Why?
|
Hemangiosarcoma | 1 | 2001 | 216 | 0.160 |
Why?
|
Pulmonary Circulation | 1 | 2021 | 743 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2020 | 225 | 0.150 |
Why?
|
Mycoplasma hominis | 1 | 2017 | 10 | 0.150 |
Why?
|
Collagen Type III | 1 | 2018 | 91 | 0.150 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 1999 | 152 | 0.150 |
Why?
|
Karyotyping | 4 | 2006 | 1171 | 0.150 |
Why?
|
GTPase-Activating Proteins | 1 | 2021 | 475 | 0.150 |
Why?
|
Cartilage | 2 | 2017 | 806 | 0.150 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2020 | 3616 | 0.150 |
Why?
|
Gene Rearrangement | 3 | 2018 | 1122 | 0.150 |
Why?
|
Resource Allocation | 1 | 2020 | 349 | 0.150 |
Why?
|
Methylation | 1 | 2020 | 1082 | 0.150 |
Why?
|
Biopsy, Needle | 5 | 2019 | 1630 | 0.150 |
Why?
|
Adenocarcinoma | 3 | 2020 | 6315 | 0.150 |
Why?
|
Metapneumovirus | 2 | 2010 | 28 | 0.150 |
Why?
|
Mycoplasma Infections | 1 | 2017 | 120 | 0.150 |
Why?
|
Empyema, Pleural | 1 | 2017 | 61 | 0.150 |
Why?
|
Tubulin | 1 | 2021 | 692 | 0.140 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2018 | 198 | 0.140 |
Why?
|
Apoptosis Inducing Factor | 1 | 2017 | 51 | 0.140 |
Why?
|
Stenotrophomonas maltophilia | 1 | 2017 | 19 | 0.140 |
Why?
|
Mitochondrial Encephalomyopathies | 1 | 2017 | 40 | 0.140 |
Why?
|
Herpesvirus 8, Human | 1 | 2019 | 255 | 0.140 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2020 | 323 | 0.140 |
Why?
|
Transsexualism | 1 | 2020 | 177 | 0.140 |
Why?
|
Blood Donors | 1 | 1999 | 343 | 0.140 |
Why?
|
Vascular Endothelial Growth Factor D | 1 | 2016 | 64 | 0.140 |
Why?
|
Oncogene Proteins | 2 | 2011 | 719 | 0.140 |
Why?
|
Follow-Up Studies | 12 | 2020 | 39261 | 0.140 |
Why?
|
Giant Cell Tumors | 1 | 2016 | 90 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 15 | 2024 | 36290 | 0.130 |
Why?
|
Vagina | 1 | 2022 | 837 | 0.130 |
Why?
|
Xanthogranuloma, Juvenile | 1 | 2016 | 16 | 0.130 |
Why?
|
Suction | 1 | 2017 | 263 | 0.130 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2019 | 446 | 0.130 |
Why?
|
Heart Diseases | 2 | 2017 | 2809 | 0.130 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2021 | 733 | 0.130 |
Why?
|
Feedback, Physiological | 2 | 2015 | 476 | 0.130 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 3 | 2014 | 544 | 0.130 |
Why?
|
Cystic Fibrosis | 3 | 2019 | 1274 | 0.130 |
Why?
|
Enterotoxins | 1 | 1997 | 366 | 0.130 |
Why?
|
Carcinoma, Squamous Cell | 7 | 2011 | 4024 | 0.130 |
Why?
|
Appendix | 1 | 2017 | 110 | 0.130 |
Why?
|
B-Lymphocytes | 2 | 2019 | 4742 | 0.130 |
Why?
|
Glycine | 1 | 2019 | 662 | 0.130 |
Why?
|
Sarcoma, Kaposi | 1 | 2019 | 376 | 0.130 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2006 | 2919 | 0.130 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2016 | 117 | 0.130 |
Why?
|
Age of Onset | 2 | 2019 | 3301 | 0.130 |
Why?
|
Pleural Neoplasms | 3 | 2008 | 609 | 0.120 |
Why?
|
Prostate-Specific Antigen | 3 | 1999 | 2529 | 0.120 |
Why?
|
Postoperative Complications | 5 | 2023 | 15697 | 0.120 |
Why?
|
Marijuana Smoking | 1 | 2018 | 257 | 0.120 |
Why?
|
Neoplasm Proteins | 6 | 2011 | 3610 | 0.120 |
Why?
|
Vaginal Neoplasms | 2 | 2005 | 104 | 0.120 |
Why?
|
Mutation | 9 | 2023 | 29932 | 0.120 |
Why?
|
PAX2 Transcription Factor | 2 | 2011 | 86 | 0.120 |
Why?
|
Receptors, Estrogen | 2 | 2005 | 2210 | 0.120 |
Why?
|
MicroRNAs | 3 | 2015 | 3790 | 0.120 |
Why?
|
Sulfur | 1 | 2015 | 163 | 0.120 |
Why?
|
Consensus | 1 | 2024 | 3113 | 0.120 |
Why?
|
Hormone Replacement Therapy | 1 | 2020 | 755 | 0.120 |
Why?
|
Fibula | 1 | 2017 | 265 | 0.120 |
Why?
|
Cell Adhesion | 1 | 2021 | 3094 | 0.120 |
Why?
|
Wrist Joint | 1 | 2016 | 265 | 0.120 |
Why?
|
Egg Hypersensitivity | 1 | 2014 | 47 | 0.120 |
Why?
|
Pathology, Surgical | 1 | 2015 | 151 | 0.120 |
Why?
|
Tongue Diseases | 1 | 2014 | 68 | 0.120 |
Why?
|
Churg-Strauss Syndrome | 2 | 2006 | 74 | 0.120 |
Why?
|
Prostatectomy | 3 | 1999 | 1956 | 0.120 |
Why?
|
Up-Regulation | 3 | 2014 | 4122 | 0.120 |
Why?
|
Pulmonary Medicine | 1 | 2016 | 221 | 0.120 |
Why?
|
Homeodomain Proteins | 2 | 2017 | 2414 | 0.120 |
Why?
|
Radiography | 4 | 2015 | 6965 | 0.120 |
Why?
|
Prognosis | 8 | 2024 | 29658 | 0.120 |
Why?
|
Heat-Shock Proteins | 1 | 1998 | 795 | 0.110 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1999 | 685 | 0.110 |
Why?
|
Breast Neoplasms | 1 | 2021 | 21025 | 0.110 |
Why?
|
Lymphangiectasis | 1 | 2014 | 20 | 0.110 |
Why?
|
Adult | 23 | 2024 | 219994 | 0.110 |
Why?
|
Mechanotransduction, Cellular | 2 | 2016 | 530 | 0.110 |
Why?
|
Embolism | 1 | 2017 | 408 | 0.110 |
Why?
|
Juxtaglomerular Apparatus | 2 | 2010 | 15 | 0.110 |
Why?
|
Respiratory Insufficiency | 2 | 2014 | 1231 | 0.110 |
Why?
|
Esophageal Atresia | 1 | 2016 | 217 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2014 | 127 | 0.110 |
Why?
|
Kidney | 5 | 2016 | 7064 | 0.110 |
Why?
|
Mastectomy | 1 | 2021 | 1832 | 0.110 |
Why?
|
Muscle Neoplasms | 1 | 2014 | 133 | 0.110 |
Why?
|
Mitochondrial Proteins | 1 | 2019 | 979 | 0.110 |
Why?
|
Foreign Bodies | 1 | 2017 | 397 | 0.110 |
Why?
|
Mice | 21 | 2024 | 81208 | 0.110 |
Why?
|
Lymphatic Metastasis | 1 | 2021 | 2943 | 0.110 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2017 | 326 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1347 | 0.110 |
Why?
|
Receptors, IgE | 1 | 2014 | 372 | 0.110 |
Why?
|
Transcription Factors | 9 | 2021 | 12103 | 0.110 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2013 | 100 | 0.110 |
Why?
|
Octamer Transcription Factor-3 | 2 | 2014 | 223 | 0.100 |
Why?
|
Transplants | 1 | 2015 | 206 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 2 | 2007 | 558 | 0.100 |
Why?
|
Biomedical Research | 2 | 2020 | 3426 | 0.100 |
Why?
|
Ultrasonography, Prenatal | 3 | 2014 | 1745 | 0.100 |
Why?
|
Mandibular Neoplasms | 1 | 2013 | 130 | 0.100 |
Why?
|
Burkholderia cepacia complex | 1 | 2012 | 24 | 0.100 |
Why?
|
Larynx | 2 | 2015 | 492 | 0.100 |
Why?
|
Selection, Genetic | 1 | 2017 | 869 | 0.100 |
Why?
|
Arthralgia | 1 | 2016 | 461 | 0.100 |
Why?
|
Laryngeal Diseases | 1 | 2015 | 244 | 0.100 |
Why?
|
Cell Lineage | 1 | 2021 | 2533 | 0.100 |
Why?
|
Pulmonary Artery | 3 | 2018 | 1921 | 0.100 |
Why?
|
Bacterial Toxins | 1 | 1997 | 931 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2013 | 2003 | 0.100 |
Why?
|
Angiomyolipoma | 1 | 2013 | 184 | 0.100 |
Why?
|
Burkholderia Infections | 1 | 2012 | 41 | 0.100 |
Why?
|
Ultrasonography | 4 | 2018 | 5961 | 0.100 |
Why?
|
Pharyngeal Diseases | 1 | 2013 | 134 | 0.100 |
Why?
|
Predictive Value of Tests | 5 | 2018 | 15289 | 0.100 |
Why?
|
Central Nervous System Neoplasms | 1 | 2020 | 916 | 0.100 |
Why?
|
Uterus | 2 | 2005 | 651 | 0.100 |
Why?
|
Esophageal Perforation | 1 | 2011 | 65 | 0.090 |
Why?
|
Lymphoproliferative Disorders | 1 | 2015 | 533 | 0.090 |
Why?
|
Bone and Bones | 2 | 2017 | 2560 | 0.090 |
Why?
|
Feces | 1 | 1997 | 1455 | 0.090 |
Why?
|
Fibrosis | 1 | 2018 | 2042 | 0.090 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2012 | 136 | 0.090 |
Why?
|
Treatment Outcome | 11 | 2018 | 65017 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2024 | 11712 | 0.090 |
Why?
|
Animals | 26 | 2024 | 167963 | 0.090 |
Why?
|
Antifungal Agents | 2 | 2024 | 749 | 0.090 |
Why?
|
Kidney Cortex | 1 | 2010 | 169 | 0.090 |
Why?
|
Genetic Markers | 1 | 2017 | 2608 | 0.090 |
Why?
|
Incidental Findings | 1 | 2015 | 698 | 0.090 |
Why?
|
Chromosome Banding | 1 | 2010 | 260 | 0.090 |
Why?
|
Signal Transduction | 8 | 2022 | 23376 | 0.090 |
Why?
|
Diaphragm | 1 | 2012 | 351 | 0.090 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2012 | 141 | 0.090 |
Why?
|
Pulmonary Fibrosis | 1 | 2014 | 506 | 0.090 |
Why?
|
Central Nervous System | 1 | 2017 | 1334 | 0.090 |
Why?
|
Eye Neoplasms | 1 | 2012 | 306 | 0.090 |
Why?
|
Myofibroma | 1 | 2010 | 45 | 0.090 |
Why?
|
Diagnostic Imaging | 3 | 2024 | 3527 | 0.090 |
Why?
|
Stromal Cells | 2 | 2005 | 1326 | 0.090 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1999 | 2418 | 0.080 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2011 | 167 | 0.080 |
Why?
|
Pericytes | 2 | 2024 | 293 | 0.080 |
Why?
|
Pelvic Neoplasms | 1 | 2011 | 248 | 0.080 |
Why?
|
Sarcoidosis | 1 | 2015 | 520 | 0.080 |
Why?
|
Unnecessary Procedures | 1 | 2013 | 413 | 0.080 |
Why?
|
Hip Joint | 1 | 2016 | 1006 | 0.080 |
Why?
|
Testosterone | 1 | 2020 | 2470 | 0.080 |
Why?
|
Acute Lung Injury | 1 | 2013 | 367 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2021 | 3486 | 0.080 |
Why?
|
Informed Consent | 1 | 2016 | 1005 | 0.080 |
Why?
|
Chromosome Deletion | 2 | 2012 | 1387 | 0.080 |
Why?
|
Cysts | 1 | 2014 | 683 | 0.080 |
Why?
|
Intraoperative Care | 1 | 2013 | 768 | 0.080 |
Why?
|
Aldosterone | 1 | 2014 | 868 | 0.080 |
Why?
|
Polysaccharides, Bacterial | 1 | 2012 | 574 | 0.080 |
Why?
|
Fetal Diseases | 1 | 2014 | 911 | 0.080 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2013 | 384 | 0.080 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2010 | 3529 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9276 | 0.080 |
Why?
|
Lingual Thyroid | 1 | 2008 | 7 | 0.080 |
Why?
|
Rats | 7 | 2024 | 23711 | 0.080 |
Why?
|
Thrombosis | 1 | 2023 | 3052 | 0.080 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2009 | 377 | 0.080 |
Why?
|
Pregnancy | 4 | 2021 | 29749 | 0.080 |
Why?
|
Monocytes | 1 | 2018 | 2575 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 5 | 2018 | 8158 | 0.080 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2015 | 608 | 0.080 |
Why?
|
Keratins | 1 | 2010 | 497 | 0.080 |
Why?
|
Lymphatic Abnormalities | 1 | 2010 | 132 | 0.080 |
Why?
|
Kidney Tubules | 1 | 2010 | 449 | 0.080 |
Why?
|
Mandible | 1 | 2013 | 750 | 0.080 |
Why?
|
Cell Line | 3 | 2018 | 15620 | 0.080 |
Why?
|
Parents | 1 | 2022 | 3549 | 0.080 |
Why?
|
Fatal Outcome | 4 | 2012 | 1832 | 0.080 |
Why?
|
Transplantation, Homologous | 1 | 2017 | 4810 | 0.080 |
Why?
|
Pneumonia | 2 | 2018 | 2131 | 0.080 |
Why?
|
Immunoglobulin E | 1 | 2014 | 1484 | 0.080 |
Why?
|
Thyroid Nodule | 1 | 2015 | 760 | 0.080 |
Why?
|
Bone Cysts, Aneurysmal | 1 | 2008 | 70 | 0.080 |
Why?
|
Vascular Diseases | 1 | 2016 | 1182 | 0.080 |
Why?
|
Stem Cells | 1 | 2021 | 3523 | 0.080 |
Why?
|
Rheumatic Diseases | 1 | 2015 | 639 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 2 | 2005 | 4490 | 0.070 |
Why?
|
Cholecystectomy | 1 | 2010 | 406 | 0.070 |
Why?
|
Mice, Inbred C57BL | 9 | 2019 | 22023 | 0.070 |
Why?
|
Angiogenesis Inhibitors | 1 | 2018 | 2049 | 0.070 |
Why?
|
Syndrome | 3 | 2021 | 3280 | 0.070 |
Why?
|
Cytogenetic Analysis | 1 | 2008 | 271 | 0.070 |
Why?
|
Mandibular Diseases | 1 | 2008 | 119 | 0.070 |
Why?
|
Prostatic Neoplasms | 3 | 1999 | 11345 | 0.070 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 2013 | 0.070 |
Why?
|
Pulmonary Embolism | 1 | 2021 | 2543 | 0.070 |
Why?
|
SOXB1 Transcription Factors | 1 | 2009 | 286 | 0.070 |
Why?
|
Paranasal Sinus Diseases | 1 | 2008 | 121 | 0.070 |
Why?
|
Deoxycholic Acid | 1 | 2007 | 53 | 0.070 |
Why?
|
Myocardial Infarction | 2 | 2018 | 11891 | 0.070 |
Why?
|
beta Catenin | 2 | 2010 | 1043 | 0.070 |
Why?
|
Nose Neoplasms | 1 | 2009 | 249 | 0.070 |
Why?
|
Mast Cells | 1 | 2014 | 1390 | 0.070 |
Why?
|
Bronchial Neoplasms | 1 | 2007 | 110 | 0.070 |
Why?
|
Amphotericin B | 1 | 2007 | 142 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 4 | 2018 | 17790 | 0.070 |
Why?
|
Genes, Wilms Tumor | 1 | 2007 | 92 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 2019 | 4433 | 0.070 |
Why?
|
Observer Variation | 1 | 2013 | 2601 | 0.070 |
Why?
|
Lymphatic System | 1 | 2008 | 254 | 0.070 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2008 | 346 | 0.070 |
Why?
|
Epiglottis | 2 | 2009 | 81 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 1 | 1999 | 3387 | 0.070 |
Why?
|
Bronchopulmonary Sequestration | 1 | 2006 | 43 | 0.070 |
Why?
|
Renin | 1 | 2008 | 635 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2016 | 2873 | 0.070 |
Why?
|
Lip | 1 | 2008 | 197 | 0.070 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2006 | 330 | 0.070 |
Why?
|
In Situ Hybridization | 2 | 2007 | 1900 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 4573 | 0.070 |
Why?
|
Liver Neoplasms | 2 | 2013 | 4319 | 0.070 |
Why?
|
Ultrasonography, Doppler | 1 | 2008 | 465 | 0.070 |
Why?
|
Antibodies, Bacterial | 1 | 2012 | 1468 | 0.070 |
Why?
|
Spermatocele | 1 | 2005 | 10 | 0.060 |
Why?
|
Cytogenetics | 1 | 2006 | 198 | 0.060 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4713 | 0.060 |
Why?
|
Vesicular Transport Proteins | 1 | 2008 | 374 | 0.060 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 2005 | 410 | 0.060 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2005 | 373 | 0.060 |
Why?
|
Airway Obstruction | 2 | 2008 | 662 | 0.060 |
Why?
|
Child Abuse | 1 | 2014 | 1067 | 0.060 |
Why?
|
Neoplasms | 4 | 2020 | 22072 | 0.060 |
Why?
|
Pulmonary Atresia | 1 | 2006 | 159 | 0.060 |
Why?
|
Neoplasm Invasiveness | 3 | 2010 | 3618 | 0.060 |
Why?
|
Algorithms | 3 | 2016 | 13981 | 0.060 |
Why?
|
Urogenital Abnormalities | 1 | 2008 | 256 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2024 | 22053 | 0.060 |
Why?
|
Image Enhancement | 2 | 2013 | 2881 | 0.060 |
Why?
|
Vincristine | 2 | 2012 | 1039 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2013 | 1347 | 0.060 |
Why?
|
Chromosomes, Human, X | 1 | 2007 | 321 | 0.060 |
Why?
|
Tomography, Emission-Computed | 1 | 2007 | 1121 | 0.060 |
Why?
|
Radiographic Image Enhancement | 2 | 2021 | 875 | 0.060 |
Why?
|
Neopterin | 1 | 2024 | 56 | 0.060 |
Why?
|
Neurofibroma | 1 | 2004 | 94 | 0.060 |
Why?
|
Optic Chiasm | 1 | 2024 | 91 | 0.060 |
Why?
|
Papilloma | 1 | 2005 | 141 | 0.060 |
Why?
|
Disease-Free Survival | 3 | 2024 | 6828 | 0.060 |
Why?
|
Sensitivity and Specificity | 4 | 2017 | 14660 | 0.060 |
Why?
|
Mycoses | 1 | 2007 | 387 | 0.060 |
Why?
|
Membrane Glycoproteins | 2 | 2018 | 3707 | 0.060 |
Why?
|
Hypertrophy | 1 | 2005 | 555 | 0.060 |
Why?
|
Editorial Policies | 1 | 2008 | 457 | 0.060 |
Why?
|
Sphenoid Bone | 1 | 2024 | 177 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 2 | 2017 | 3620 | 0.050 |
Why?
|
Dendritic Cells | 1 | 2014 | 2725 | 0.050 |
Why?
|
High-Frequency Ventilation | 1 | 2003 | 88 | 0.050 |
Why?
|
Pleural Effusion | 1 | 2006 | 342 | 0.050 |
Why?
|
DNA, Neoplasm | 2 | 2006 | 1745 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5508 | 0.050 |
Why?
|
Hand | 1 | 2008 | 903 | 0.050 |
Why?
|
Inclusion Bodies | 1 | 2004 | 281 | 0.050 |
Why?
|
Mice, Transgenic | 4 | 2021 | 9530 | 0.050 |
Why?
|
Leukotriene Antagonists | 1 | 2003 | 123 | 0.050 |
Why?
|
Rodentia | 1 | 2024 | 260 | 0.050 |
Why?
|
Lung Diseases, Fungal | 1 | 2003 | 126 | 0.050 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2023 | 276 | 0.050 |
Why?
|
Normetanephrine | 1 | 2021 | 25 | 0.050 |
Why?
|
Ureteral Neoplasms | 1 | 2003 | 110 | 0.050 |
Why?
|
Kidney Pelvis | 1 | 2003 | 188 | 0.050 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2004 | 748 | 0.050 |
Why?
|
PPAR gamma | 2 | 2015 | 484 | 0.050 |
Why?
|
Eye Abnormalities | 1 | 2024 | 241 | 0.050 |
Why?
|
Skin | 2 | 2008 | 4466 | 0.050 |
Why?
|
Cells, Cultured | 4 | 2021 | 18957 | 0.050 |
Why?
|
Microscopy, Electron | 1 | 2005 | 2558 | 0.050 |
Why?
|
Hepatic Artery | 1 | 2023 | 230 | 0.050 |
Why?
|
Phenotype | 4 | 2024 | 16546 | 0.050 |
Why?
|
Pulmonary Gas Exchange | 1 | 2003 | 378 | 0.050 |
Why?
|
DNA-Binding Proteins | 3 | 2022 | 9585 | 0.050 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2001 | 57 | 0.050 |
Why?
|
Anemia, Sickle Cell | 1 | 2010 | 1056 | 0.050 |
Why?
|
Aged | 10 | 2020 | 169152 | 0.050 |
Why?
|
Cyclophosphamide | 2 | 2012 | 2221 | 0.050 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2003 | 241 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5643 | 0.050 |
Why?
|
Bronchoscopy | 2 | 2024 | 911 | 0.050 |
Why?
|
Dactinomycin | 1 | 2001 | 304 | 0.050 |
Why?
|
Cicatrix | 1 | 2007 | 782 | 0.050 |
Why?
|
Ureteral Obstruction | 1 | 2003 | 292 | 0.050 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2016 | 686 | 0.050 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2001 | 57 | 0.050 |
Why?
|
Antibodies, Monoclonal | 4 | 2009 | 9185 | 0.050 |
Why?
|
Hypertension | 1 | 2021 | 8594 | 0.050 |
Why?
|
Chromogranins | 1 | 2021 | 161 | 0.050 |
Why?
|
Aspergillosis | 1 | 2003 | 243 | 0.050 |
Why?
|
Risk Factors | 4 | 2020 | 74359 | 0.050 |
Why?
|
Cell Nucleus | 1 | 2010 | 2907 | 0.050 |
Why?
|
Pulmonary Valve | 1 | 2005 | 414 | 0.050 |
Why?
|
Pulmonary Emphysema | 1 | 2006 | 688 | 0.050 |
Why?
|
Methyltransferases | 1 | 2024 | 374 | 0.050 |
Why?
|
Survival Rate | 5 | 2019 | 12808 | 0.050 |
Why?
|
Doxorubicin | 2 | 2012 | 2209 | 0.050 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2024 | 316 | 0.050 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2008 | 1245 | 0.050 |
Why?
|
Lymphocytosis | 1 | 2021 | 119 | 0.040 |
Why?
|
Receptors, Progesterone | 1 | 2005 | 1130 | 0.040 |
Why?
|
Pregnancy Trimester, Second | 1 | 2003 | 732 | 0.040 |
Why?
|
Portal Vein | 1 | 2023 | 429 | 0.040 |
Why?
|
Gene Silencing | 1 | 2007 | 1513 | 0.040 |
Why?
|
Mouth | 1 | 2003 | 380 | 0.040 |
Why?
|
Cytokinesis | 1 | 2021 | 172 | 0.040 |
Why?
|
Mediastinum | 1 | 2021 | 266 | 0.040 |
Why?
|
Pharynx | 1 | 2003 | 432 | 0.040 |
Why?
|
Oncogene Fusion | 1 | 2020 | 81 | 0.040 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2021 | 235 | 0.040 |
Why?
|
Aortic Aneurysm | 1 | 2005 | 648 | 0.040 |
Why?
|
Leukocytosis | 1 | 2021 | 251 | 0.040 |
Why?
|
Pneumonia, Bacterial | 1 | 2003 | 319 | 0.040 |
Why?
|
Respiratory Mechanics | 1 | 2003 | 699 | 0.040 |
Why?
|
Hyperglycemia | 1 | 2008 | 1380 | 0.040 |
Why?
|
Tissue Banks | 1 | 2020 | 184 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcr | 1 | 1999 | 19 | 0.040 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2005 | 594 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 1998 | 5251 | 0.040 |
Why?
|
Embryonic Stem Cells | 3 | 2013 | 1262 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2017 | 5649 | 0.040 |
Why?
|
Trachea | 2 | 2016 | 1082 | 0.040 |
Why?
|
Receptors, Immunologic | 1 | 2005 | 1411 | 0.040 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 1999 | 222 | 0.040 |
Why?
|
Random Allocation | 2 | 2014 | 2394 | 0.040 |
Why?
|
Adrenal Glands | 1 | 2021 | 554 | 0.040 |
Why?
|
Abnormalities, Multiple | 3 | 2012 | 1415 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7475 | 0.040 |
Why?
|
Cell Respiration | 1 | 2019 | 202 | 0.040 |
Why?
|
Brain Stem | 1 | 2024 | 857 | 0.040 |
Why?
|
Pulmonary Alveoli | 2 | 2016 | 653 | 0.040 |
Why?
|
Receptor, trkC | 1 | 2018 | 63 | 0.040 |
Why?
|
Orthomyxoviridae Infections | 1 | 2021 | 250 | 0.040 |
Why?
|
Ganciclovir | 1 | 2019 | 252 | 0.040 |
Why?
|
Cell Proliferation | 2 | 2014 | 10446 | 0.040 |
Why?
|
Disease Models, Animal | 5 | 2019 | 18137 | 0.040 |
Why?
|
Chromatin | 1 | 2010 | 2938 | 0.040 |
Why?
|
Pseudomonas Infections | 1 | 2003 | 623 | 0.040 |
Why?
|
Thorax | 1 | 2021 | 553 | 0.040 |
Why?
|
Smad3 Protein | 1 | 2018 | 167 | 0.040 |
Why?
|
Neck | 2 | 2016 | 731 | 0.040 |
Why?
|
Anti-Asthmatic Agents | 1 | 2003 | 565 | 0.040 |
Why?
|
Hyperplasia | 1 | 2021 | 1155 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2021 | 568 | 0.040 |
Why?
|
Receptor, trkB | 1 | 2018 | 125 | 0.040 |
Why?
|
Creatine Kinase | 1 | 1999 | 691 | 0.040 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2021 | 448 | 0.040 |
Why?
|
Periodicals as Topic | 1 | 2008 | 1469 | 0.040 |
Why?
|
Receptors, CCR2 | 1 | 2018 | 215 | 0.040 |
Why?
|
Tidal Volume | 2 | 2013 | 487 | 0.030 |
Why?
|
Myocardial Ischemia | 1 | 2007 | 2164 | 0.030 |
Why?
|
Cell Movement | 2 | 2022 | 5206 | 0.030 |
Why?
|
Homozygote | 1 | 2021 | 1788 | 0.030 |
Why?
|
Alleles | 2 | 2024 | 6898 | 0.030 |
Why?
|
Neprilysin | 1 | 1999 | 472 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2019 | 3442 | 0.030 |
Why?
|
Preoperative Period | 1 | 2018 | 555 | 0.030 |
Why?
|
Electron Transport | 1 | 2017 | 206 | 0.030 |
Why?
|
Antigens, CD19 | 1 | 1999 | 424 | 0.030 |
Why?
|
Neoplasm Staging | 4 | 2011 | 11152 | 0.030 |
Why?
|
Recurrence | 2 | 2005 | 8482 | 0.030 |
Why?
|
Angiography | 1 | 2021 | 1605 | 0.030 |
Why?
|
Middle Aged | 12 | 2024 | 220352 | 0.030 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2009 | 693 | 0.030 |
Why?
|
Nicotine | 1 | 2020 | 677 | 0.030 |
Why?
|
Limb Deformities, Congenital | 1 | 2016 | 136 | 0.030 |
Why?
|
Reference Standards | 1 | 1999 | 1004 | 0.030 |
Why?
|
Asthma | 1 | 2014 | 6172 | 0.030 |
Why?
|
Chemokine CCL2 | 1 | 2018 | 605 | 0.030 |
Why?
|
Toe Joint | 1 | 2015 | 19 | 0.030 |
Why?
|
Neuropeptides | 1 | 2021 | 943 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1997 | 1628 | 0.030 |
Why?
|
LDL-Receptor Related Proteins | 1 | 2015 | 118 | 0.030 |
Why?
|
Cisplatin | 1 | 2001 | 1644 | 0.030 |
Why?
|
Cell Migration Assays | 1 | 2014 | 21 | 0.030 |
Why?
|
Tracheoesophageal Fistula | 1 | 2016 | 131 | 0.030 |
Why?
|
Cytokines | 2 | 2024 | 7343 | 0.030 |
Why?
|
Pseudomonas aeruginosa | 1 | 2003 | 1276 | 0.030 |
Why?
|
Potassium | 1 | 1999 | 1313 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2007 | 12766 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2013 | 20080 | 0.030 |
Why?
|
Papain | 1 | 2014 | 65 | 0.030 |
Why?
|
Aortic Valve | 1 | 2005 | 1996 | 0.030 |
Why?
|
Models, Animal | 1 | 2021 | 2117 | 0.030 |
Why?
|
Biological Assay | 1 | 1997 | 630 | 0.030 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11903 | 0.030 |
Why?
|
Chickens | 1 | 2016 | 860 | 0.030 |
Why?
|
Systems Biology | 1 | 2018 | 482 | 0.030 |
Why?
|
Finger Joint | 1 | 2015 | 108 | 0.030 |
Why?
|
Immunophenotyping | 1 | 1999 | 1871 | 0.030 |
Why?
|
Receptors, Androgen | 1 | 2020 | 1077 | 0.030 |
Why?
|
Systems Theory | 1 | 2014 | 57 | 0.030 |
Why?
|
Protein Binding | 2 | 2018 | 9335 | 0.030 |
Why?
|
Hemorrhage | 2 | 2023 | 3600 | 0.030 |
Why?
|
Surgical Flaps | 1 | 2003 | 1669 | 0.030 |
Why?
|
Cell Division | 1 | 2001 | 4463 | 0.030 |
Why?
|
Uteroglobin | 1 | 2014 | 56 | 0.030 |
Why?
|
Necrosis | 2 | 2010 | 1612 | 0.030 |
Why?
|
Anal Canal | 1 | 2016 | 372 | 0.030 |
Why?
|
Sodium | 1 | 1999 | 1594 | 0.030 |
Why?
|
Prospective Studies | 3 | 2022 | 54303 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2016 | 747 | 0.030 |
Why?
|
Gene Regulatory Networks | 2 | 2014 | 1741 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2019 | 1791 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2014 | 119 | 0.030 |
Why?
|
Pedigree | 1 | 2021 | 4578 | 0.030 |
Why?
|
Cartilage Diseases | 1 | 2015 | 156 | 0.030 |
Why?
|
Family | 2 | 2016 | 3189 | 0.030 |
Why?
|
Phagocytosis | 2 | 2012 | 1535 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2003 | 1796 | 0.030 |
Why?
|
Mitochondrial Diseases | 1 | 2017 | 340 | 0.030 |
Why?
|
Patient Care Team | 1 | 2024 | 2511 | 0.030 |
Why?
|
Hemodynamics | 1 | 2003 | 4174 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2019 | 2222 | 0.030 |
Why?
|
Ovalbumin | 1 | 2014 | 674 | 0.030 |
Why?
|
Shoulder | 1 | 2014 | 299 | 0.030 |
Why?
|
Muscular Diseases | 1 | 2017 | 551 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2015 | 585 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 2003 | 2622 | 0.030 |
Why?
|
Blood Bactericidal Activity | 1 | 2012 | 126 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2014 | 590 | 0.020 |
Why?
|
Drug Therapy, Combination | 2 | 2018 | 6498 | 0.020 |
Why?
|
Topotecan | 1 | 2012 | 132 | 0.020 |
Why?
|
Sus scrofa | 1 | 2013 | 433 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2017 | 858 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2005 | 317 | 0.020 |
Why?
|
Molecular Sequence Data | 4 | 2007 | 17624 | 0.020 |
Why?
|
Cross-Linking Reagents | 1 | 2014 | 685 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2022 | 2628 | 0.020 |
Why?
|
Paclitaxel | 1 | 2019 | 1736 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2014 | 1763 | 0.020 |
Why?
|
Immunity, Mucosal | 1 | 2014 | 482 | 0.020 |
Why?
|
Brachytherapy | 1 | 1999 | 1238 | 0.020 |
Why?
|
United States | 4 | 2022 | 72461 | 0.020 |
Why?
|
Hernia, Diaphragmatic | 1 | 2012 | 246 | 0.020 |
Why?
|
Pulmonary Edema | 1 | 2014 | 409 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2016 | 1167 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2015 | 2502 | 0.020 |
Why?
|
Xanthenes | 1 | 2010 | 72 | 0.020 |
Why?
|
Bronchiolitis Obliterans | 1 | 2012 | 213 | 0.020 |
Why?
|
Esophagus | 1 | 2016 | 1023 | 0.020 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 1 | 2010 | 31 | 0.020 |
Why?
|
Blood Platelets | 1 | 2021 | 2520 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2008 | 15840 | 0.020 |
Why?
|
Alphapapillomavirus | 1 | 2013 | 218 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2014 | 877 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4899 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2015 | 1436 | 0.020 |
Why?
|
Head | 1 | 2016 | 922 | 0.020 |
Why?
|
Spine | 1 | 2016 | 1111 | 0.020 |
Why?
|
Carcinoma, Renal Cell | 1 | 2005 | 3218 | 0.020 |
Why?
|
Laser Therapy | 2 | 2008 | 1089 | 0.020 |
Why?
|
Esophagoscopy | 1 | 2011 | 390 | 0.020 |
Why?
|
Lymphatic Vessels | 1 | 2014 | 358 | 0.020 |
Why?
|
Europe | 1 | 2016 | 3441 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2019 | 14372 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2012 | 863 | 0.020 |
Why?
|
Phylogeny | 1 | 2017 | 2775 | 0.020 |
Why?
|
Tissue Donors | 1 | 2019 | 2313 | 0.020 |
Why?
|
Boston | 2 | 2016 | 9280 | 0.020 |
Why?
|
Nephrons | 1 | 2010 | 168 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2013 | 1493 | 0.020 |
Why?
|
Mechanoreceptors | 1 | 2010 | 187 | 0.020 |
Why?
|
Cervix Uteri | 1 | 2013 | 582 | 0.020 |
Why?
|
Positive-Pressure Respiration | 1 | 2013 | 636 | 0.020 |
Why?
|
Electric Impedance | 1 | 2013 | 755 | 0.020 |
Why?
|
Sclerotherapy | 1 | 2010 | 181 | 0.020 |
Why?
|
Linear Models | 1 | 1999 | 5877 | 0.020 |
Why?
|
Body Fluids | 1 | 2010 | 319 | 0.020 |
Why?
|
Malonates | 1 | 2008 | 43 | 0.020 |
Why?
|
Flow Cytometry | 1 | 1999 | 5870 | 0.020 |
Why?
|
Cell Cycle Proteins | 3 | 2005 | 3446 | 0.020 |
Why?
|
Glossectomy | 1 | 2008 | 60 | 0.020 |
Why?
|
Down Syndrome | 1 | 2016 | 892 | 0.020 |
Why?
|
Citrates | 1 | 2008 | 135 | 0.020 |
Why?
|
Acetylation | 1 | 2011 | 1062 | 0.020 |
Why?
|
Sodium Chloride | 1 | 2010 | 591 | 0.020 |
Why?
|
Epithelium | 1 | 2013 | 1605 | 0.020 |
Why?
|
Methotrexate | 1 | 2015 | 1719 | 0.020 |
Why?
|
Hydroxamic Acids | 1 | 2011 | 482 | 0.020 |
Why?
|
Glottis | 1 | 2009 | 214 | 0.020 |
Why?
|
Collagen | 1 | 2016 | 2636 | 0.020 |
Why?
|
Kidney Glomerulus | 1 | 2010 | 568 | 0.020 |
Why?
|
Succinic Acid | 1 | 2008 | 84 | 0.020 |
Why?
|
Serologic Tests | 1 | 2010 | 383 | 0.020 |
Why?
|
Disease Management | 1 | 2018 | 2514 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2007 | 6659 | 0.020 |
Why?
|
Video Recording | 1 | 2013 | 955 | 0.020 |
Why?
|
Sex Factors | 1 | 2001 | 10547 | 0.020 |
Why?
|
Thyroid Function Tests | 1 | 2008 | 289 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2010 | 858 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2013 | 2932 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4897 | 0.020 |
Why?
|
Drug Resistance, Fungal | 1 | 2007 | 73 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2010 | 698 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1652 | 0.020 |
Why?
|
Allergens | 1 | 2014 | 1402 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2014 | 2209 | 0.020 |
Why?
|
Paracrine Communication | 1 | 2008 | 277 | 0.020 |
Why?
|
Trans-Activators | 1 | 2016 | 2860 | 0.020 |
Why?
|
Organogenesis | 1 | 2008 | 215 | 0.020 |
Why?
|
Thyroid Diseases | 1 | 2010 | 386 | 0.020 |
Why?
|
Hepatectomy | 1 | 2010 | 559 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1617 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2016 | 2640 | 0.020 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2007 | 276 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2011 | 772 | 0.020 |
Why?
|
Endothelium | 1 | 2008 | 764 | 0.020 |
Why?
|
Face | 1 | 2012 | 1017 | 0.020 |
Why?
|
Reference Values | 1 | 2013 | 4925 | 0.020 |
Why?
|
Perfusion | 1 | 2010 | 1376 | 0.020 |
Why?
|
Pelvic Pain | 1 | 2008 | 298 | 0.020 |
Why?
|
Dinoprostone | 1 | 2008 | 598 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 1955 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 1999 | 12159 | 0.020 |
Why?
|
Antirheumatic Agents | 1 | 2015 | 1374 | 0.020 |
Why?
|
Tongue | 1 | 2008 | 404 | 0.020 |
Why?
|
Aniline Compounds | 1 | 2010 | 1069 | 0.020 |
Why?
|
Pharyngectomy | 1 | 2004 | 44 | 0.020 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2008 | 304 | 0.020 |
Why?
|
Iodine Radioisotopes | 1 | 2008 | 1032 | 0.010 |
Why?
|
Aerosols | 1 | 2007 | 632 | 0.010 |
Why?
|
Mice, Nude | 1 | 2011 | 3607 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2013 | 6238 | 0.010 |
Why?
|
Chromosomes, Human, 19-20 | 1 | 2003 | 11 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3696 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1881 | 0.010 |
Why?
|
Chromosomes, Human, 13-15 | 1 | 2003 | 49 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2008 | 1975 | 0.010 |
Why?
|
Tracheotomy | 1 | 2004 | 167 | 0.010 |
Why?
|
Air Pressure | 1 | 2003 | 74 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 6216 | 0.010 |
Why?
|
Physical Examination | 1 | 2010 | 1244 | 0.010 |
Why?
|
Societies, Medical | 1 | 2016 | 3905 | 0.010 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2003 | 144 | 0.010 |
Why?
|
Calcium Signaling | 1 | 2008 | 732 | 0.010 |
Why?
|
Mitochondria | 1 | 2017 | 3600 | 0.010 |
Why?
|
Tumor Stem Cell Assay | 1 | 2003 | 115 | 0.010 |
Why?
|
Time Factors | 2 | 2010 | 40165 | 0.010 |
Why?
|
Helix-Loop-Helix Motifs | 1 | 2003 | 96 | 0.010 |
Why?
|
Exudates and Transudates | 1 | 2003 | 175 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2014 | 2056 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8552 | 0.010 |
Why?
|
Apoptosis | 1 | 1999 | 9501 | 0.010 |
Why?
|
Swine | 1 | 2013 | 5899 | 0.010 |
Why?
|
Transfection | 1 | 2011 | 5781 | 0.010 |
Why?
|
Research | 1 | 2011 | 1974 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2015 | 4541 | 0.010 |
Why?
|
Base Sequence | 2 | 2005 | 12446 | 0.010 |
Why?
|
Titanium | 1 | 2005 | 484 | 0.010 |
Why?
|
Laryngectomy | 1 | 2004 | 243 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2011 | 2379 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 2010 | 1266 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2010 | 1913 | 0.010 |
Why?
|
Cough | 1 | 2006 | 595 | 0.010 |
Why?
|
Antigens, CD34 | 1 | 2004 | 653 | 0.010 |
Why?
|
Fractures, Bone | 1 | 2014 | 2041 | 0.010 |
Why?
|
Respiratory Tract Infections | 1 | 2010 | 1007 | 0.010 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2008 | 1112 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13502 | 0.010 |
Why?
|
Rabbits | 1 | 2008 | 4773 | 0.010 |
Why?
|
Granulocytes | 1 | 2003 | 551 | 0.010 |
Why?
|
Point Mutation | 1 | 2007 | 1594 | 0.010 |
Why?
|
Eosinophils | 1 | 2006 | 944 | 0.010 |
Why?
|
Pneumonectomy | 1 | 2008 | 1111 | 0.010 |
Why?
|
Blotting, Southern | 1 | 2001 | 777 | 0.010 |
Why?
|
Drug Combinations | 1 | 2007 | 2025 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21392 | 0.010 |
Why?
|
Papillomavirus Infections | 1 | 2013 | 1607 | 0.010 |
Why?
|
Sheep | 1 | 2003 | 1441 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14495 | 0.010 |
Why?
|
Brain Diseases | 1 | 2010 | 1540 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6218 | 0.010 |
Why?
|
Interleukin-8 | 1 | 2003 | 698 | 0.010 |
Why?
|
Vocal Cords | 1 | 2005 | 523 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2010 | 2828 | 0.010 |
Why?
|
Introns | 1 | 2003 | 978 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2010 | 1413 | 0.010 |
Why?
|
Heterozygote | 1 | 2007 | 2798 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2003 | 1249 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2016 | 4673 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2003 | 1156 | 0.010 |
Why?
|
Medical Oncology | 1 | 2011 | 2313 | 0.010 |
Why?
|
Neurofibromatosis 1 | 1 | 2004 | 560 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2008 | 2141 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6544 | 0.010 |
Why?
|
Chest Pain | 1 | 2006 | 1106 | 0.010 |
Why?
|
Laryngoscopy | 1 | 2004 | 706 | 0.010 |
Why?
|
Virulence | 1 | 2003 | 1298 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2010 | 3604 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2007 | 2007 | 0.010 |
Why?
|
DNA Primers | 1 | 2003 | 2819 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2010 | 2821 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3800 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18416 | 0.010 |
Why?
|
Protein Kinases | 1 | 2005 | 1612 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15687 | 0.010 |
Why?
|
Models, Biological | 1 | 2014 | 9467 | 0.010 |
Why?
|
Genes | 1 | 2001 | 1845 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2007 | 2634 | 0.010 |
Why?
|
Steroids | 1 | 2003 | 928 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13630 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2003 | 4169 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10181 | 0.010 |
Why?
|
Blotting, Western | 1 | 2005 | 5039 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2001 | 1697 | 0.010 |
Why?
|
Alternative Splicing | 1 | 2001 | 1091 | 0.010 |
Why?
|
Glucose | 1 | 2008 | 4351 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2010 | 7593 | 0.010 |
Why?
|
Immunotherapy | 1 | 2012 | 4642 | 0.010 |
Why?
|
DNA Methylation | 1 | 2010 | 4373 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 2007 | 1913 | 0.010 |
Why?
|
Laparoscopy | 1 | 2008 | 2147 | 0.010 |
Why?
|
Intubation, Intratracheal | 1 | 2003 | 1328 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 13314 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2011 | 6465 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2007 | 13451 | 0.010 |
Why?
|
Weight Loss | 1 | 2006 | 2686 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2003 | 4625 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2001 | 6131 | 0.010 |
Why?
|
Gene Expression | 1 | 2007 | 7588 | 0.010 |
Why?
|
Oxygen | 1 | 2003 | 4193 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12626 | 0.010 |
Why?
|
Risk Assessment | 1 | 2010 | 24123 | 0.000 |
Why?
|
Chronic Disease | 1 | 2003 | 9287 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2011 | 58995 | 0.000 |
Why?
|